Deutsche Bank
IMUC

Deutsche Bank’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Deutsche Bank’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Hold
0
– – – 5354
2016
Q3 		– Hold
0
– – – 5615
2016
Q2 		– Hold
0
– – – 5655
2016
Q1 		– Hold
0
– – – 5662
2015
Q4 		– Sell
-63
Closed -$1.04K – 5683
2015
Q3 		$1K Sell
63
-9,128
-99% -$166K ﹤0.01% 5165
2015
Q2 		$173K Buy
9,191
+7,520
+450% +$145K ﹤0.01% 3961
2015
Q1 		$32K Buy
1,671
+569
+52% +$14.3K ﹤0.01% 4526
2014
Q4 		$32K Sell
1,102
-2,969
-73% -$85.4K ﹤0.01% 5357
2014
Q3 		$144K Buy
4,071
+250
+7% +$9.63K ﹤0.01% 4275
2014
Q2 		$170K Buy
3,821
+1,258
+49% +$60.7K ﹤0.01% 4236
2014
Q1 		$125K Buy
2,563
+2,560
+85,333% +$125K ﹤0.01% 4134
2013
Q4 		$0 Sell
3
-997
-100% -$94.4K ﹤0.01% 6152
2013
Q3 		$102K Sell
1,000
-2,367
-70% -$260K ﹤0.01% 4424
2013
Q2 		$261K Buy
+3,367
New +$322K ﹤0.01% 3644

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return